Laurus Labs has invested Rs 83.30 crore and acquired 83,300,000 equity shares of KRKA Pharma (KRKA) (a joint venture of the Company) a at face value of Rs 10 each by way of rights issue.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C.